Implantable Loop Recorders Market

Global Implantable Loop Recorders Market By Application (Atrial fibrillation, Cardiac Arrhythmia and Cardiac syncope), By End User (Hospitals, Cardiac Centers and Other End Users), By Region, Industry Analysis and Forecast, 2020 - 2026

Report Id: KBV-4520 Publication Date: August-2020 Number of Pages: 139
Special Offering:
Industry Insights | Market Trends
Highest number of Tables | 24/7 Analyst Support

Market Report Description

The Global Implantable Loop Recorders Market size is expected to reach $2.1 billion by 2026, rising at a market growth of 11.9% CAGR during the forecast period. The implantable loop recorder (ILR) is a portable cardiac recording system capable of continuously saving ECG data in the case of bradyarrhythmia or tachyarrhythmia. This is inserted under the skin where the pocket on the left side of the breastbone is shaped. ILR is often seen in people with conditions such as syncope, repeated palpitations, skipped beats, light-headedness, or dizziness.

Global Implantable Loop Recorders Market Size

Implantable Loop Recorders Market Size

Syncope is a sudden loss of control caused by systemic arterial hypotension related to excessive vasodilatation or bradycardia or both. Unexplained Syncope applies to the form of syncope where no specific cardiologic or neurological explanation can be made. Implantable loop recorders (ILRs) may help try to discern between various types of temporary lack of consciousness.

The ILR has a safe and effective way to monitor patients with recurrent unexplained syncope. ILR is a subcutaneous, single-lead, electrocardiographic (ECG) monitoring system used for the treatment of patients with chronic abnormal palpitation or syncope events, coupled with long-term surveillance of patients at risk of or with atrial fibrillation, systemic heart failure, bundle branch obstruction, persistent neural induced syncope, etc. This consists of an insertable unit, which comes with a battery and two surface electrodes.

Implantable Loop Recorders Market Share

Implantable Loop Recorders Market Share

Technological advances are anticipated to play a vital role in the introduction of new-age implantable loop recorders. Stakeholders competing in the existing business environment implantable loop recorders are anticipated to develop stronger and 'smarter' implantable loop recorders during the prediction timeframe to increase their consumer presence. Manufacturers in the market for implantable loop recorders are introducing new products that can be attached to mobile applications through Bluetooth and Wi-Fi.

Free Valuable Insights: Global Implantable Loop Recorders Market to reach a market size of $2.1 billion by 2026

Based on Application, the market is segmented into Atrial fibrillation, Cardiac Arrhythmia and Cardiac syncope. Based on End User, the market is segmented into Hospitals, Cardiac Centers and Other End Users. Based on Regions, the market is segmented into North America, Europe, Asia Pacific, and Latin America, Middle East & Africa.

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Medtronic PLC, Abbott Laboratories, Boston Scientific Corporation, BIOTRONIK SE & Co. KG, Angel Medical Systems, Inc., and Vectorious Medical Technologies Ltd.

Recent Strategies Implantable Loop Recorders Market

  • Jul-2020: Medtronic got FDA clearance for its LINQ II insertable cardiac monitor. This cardiac monitor has been used for the detection and classification of cardiac arrhythmias and remote monitoring of patients. The LINQ II features remote programming capabilities, enabling cardiologists to tune the implant settings without the patient having to come into the office.
  • Jun-2020: Boston Scientific received U.S. Food and Drug Administration approval for the LUX-Dx Insertable Cardiac Monitor (ICM) System, a new, long-term diagnostic device. The device is being implanted in patients to detect arrhythmias associated with conditions such as atrial fibrillation (AF), cryptogenic stroke and syncope.
  • Jun-2019: BIOTRONIK introduced a new version of its BIOMONITOR injectable cardiac monitor, BIOMONITOR II. This has been designed to be injected under the skin, where it can reside for up to four years while continuously monitoring and recording the patient’s electrical heart signals.
  • May-2019: Abbott launched the latest generation of the Confirm Rx insertable cardiac monitor. The new device delivers more accurate detection of cardiac arrhythmias. The implant is inserted through a small incision during an outpatient procedure and is able to communicate with a paired-up smartphone via Bluetooth while continuously monitoring the beating heart.
  • Mar-2017: Medtronic received FDA approval for its next-gen Reveal Linq insertable cardiac monitor with TruRhythm Detection. The Linq ICM with TruRhythm Detection provides exclusive algorithms.

Scope of the Implantable Loop Recorders Market Analysis

Market Segmentation:

By Application

  • Atrial fibrillation
  • Cardiac Arrhythmia
  • Cardiac syncope

By End-User

  • Hospitals
  • Cardiac Centers
  • Other End Users

By Geography

  • North America
    • US
    • Canada
    • Mexico
    • Rest of North America
  • Europe
    • Germany
    • UK
    • France
    • Russia
    • Spain
    • Italy
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Singapore
    • Malaysia
    • Rest of Asia Pacific
    • Brazil
    • Argentina
    • UAE
    • Saudi Arabia
    • South Africa
    • Nigeria
    • Rest of LAMEA

Companies Profiled

  • Medtronic PLC
  • Abbott Laboratories
  • Boston Scientific Corporation
  • Angel Medical Systems, Inc.
  • Vectorious Medical Technologies Ltd.
Need a report that reflects how COVID-19 has impacted this market and its growth? Download Free Sample Now

Frequently Asked Questions About This Report

The implantable loop recorders market is projected to reach USD 2.1 billion by 2026.

The major factors that are anticipated to drive the implantable loop recorders industry include demand for remote patient monitoring amid the coronavirus (COVID-19) outbreak.

Medtronic PLC, Abbott Laboratories, Boston Scientific Corporation, BIOTRONIK SE & Co. KG, Angel Medical Systems, Inc., and Vectorious Medical Technologies Ltd.

The hospital segment recorded a dominant market share. The dominance of the segment may be attributed to an improvement in the number of minimally invasive surgeries in such hospitals.



Call: +1(646) 600-5072


  • Buy Sections of This Report
  • Buy Country Level Reports
  • Request for Historical Data
  • Discounts Available for Start-Ups & Universities

Unique Offerings Unique Offerings

  • Exhaustive coverage
  • The highest number of Market tables and figures
  • Subscription-based model available
  • Guaranteed best price
  • Support with 10% customization free after sale

Trusted by over
5000+ clients

Our team of dedicated experts can provide you with attractive expansion opportunities for your business.

Client Logo